» Articles » PMID: 33649088

Neonatal Encephalopathy: Beyond Hypoxic-Ischemic Encephalopathy

Overview
Journal Neoreviews
Date 2021 Mar 2
PMID 33649088
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Neonatal encephalopathy is a clinical syndrome of neurologic dysfunction that encompasses a broad spectrum of symptoms and severity, from mild irritability and feeding difficulties to coma and seizures. It is vital for providers to understand that the term "neonatal encephalopathy" is simply a description of the neonate's neurologic status that is agnostic to the underlying etiology. Unfortunately, hypoxic-ischemic encephalopathy (HIE) has become common vernacular to describe any neonate with encephalopathy, but this can be misleading. The term should not be used unless there is evidence of perinatal asphyxia as the primary cause of encephalopathy. HIE is a common cause of neonatal encephalopathy; the differential diagnosis also includes conditions with infectious, vascular, epileptic, genetic/congenital, metabolic, and toxic causes. Because neonatal encephalopathy is estimated to affect 2 to 6 per 1,000 term births, of which HIE accounts for approximately 1.5 per 1,000 term births, (1)(2)(3)(4)(5)(6) neonatologists and child neurologists should familiarize themselves with the evaluation, diagnosis, and treatment of the diverse causes of neonatal encephalopathy. This review begins by discussing HIE, but also helps practitioners extend the differential to consider the broad array of other causes of neonatal encephalopathy, emphasizing the epidemiology, neurologic presentations, diagnostics, imaging findings, and therapeutic strategies for each potential category.

Citing Articles

Cardiac biomarkers predict low right ventricle performance in neonatal encephalopathy.

Moore S, Lapointe A, Rampakakis E, Simoneau J, Elias P, Poccia A J Perinatol. 2025; .

PMID: 40089578 DOI: 10.1038/s41372-025-02262-9.


The effect of using dexmedetomidine versus morphine as sedation on long-term neurodevelopmental outcomes of encephalopathic neonates undergoing therapeutic hypothermia.

Nuzum T, Kazmi S, Wachtel E J Perinatol. 2025; .

PMID: 39979431 DOI: 10.1038/s41372-025-02227-y.


Brain MRI T2 hyperintensity and neurodevelopmental outcomes in neonatal encephalopathy.

Christensen R, Widjaja E, Kamino D, Mamak E, Ly L, Tam E Pediatr Res. 2025; .

PMID: 39905143 DOI: 10.1038/s41390-025-03907-3.


Features of Physical and Psychomotor Development in Children with Brain Ischemia.

O Shoibekova G, N Turbekova M, A Iskakova F, B Altynbayeva G, Ospanova E, S Malgazhdarov M Med J Islam Repub Iran. 2025; 38():110.

PMID: 39781321 PMC: 11707707. DOI: 10.47176/mjiri.38.110.


Detection of neurologic changes in critically ill infants using deep learning on video data: a retrospective single center cohort study.

Gleason A, Richter F, Beller N, Arivazhagan N, Feng R, Holmes E EClinicalMedicine. 2025; 78():102919.

PMID: 39764545 PMC: 11701473. DOI: 10.1016/j.eclinm.2024.102919.